| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3577 | Nc2213 | Novel inhibitor of methionine aminopeptidase 2 (MetAP2) |
|
| DCC3578 | Ncats-sm1440 | First-in-class, potent, and selective Lactate dehydrogenase inhibitor |
|
| DCC3579 | Ncats-sm1441 | First-in-class, potent, and selective Lactate dehydrogenase inhibitor |
|
| DCC3580 | Ncb0970 | Less active trans-isomer of NCB-0846, acting as the negative control for NCB-0846, showing 13-fold weaker TNIK enzyme-inhibitory activity |
|
| DCC3581 | Ncdm-32 | Potent pan KDM Inhibitor, inhibiting KDM2A, KDM7A, KDM7B, KDM4A, KDM4C, and KDM5A |
|
| DCC3582 | Ncgc00117362 | Novel inhibitor of ovarian cancer metastasis, adhesion, invasion and proliferation |
|
| DCC3583 | Ncgc00120943 | Novel Agonist for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions |
|
| DCC3584 | ncgc00161856 | The first small-molecule inverse agonist for the thyroid-stimulating hormone receptor (TSHR) |
|
| DCC3585 | ncgc00242595 | TSHR neutral antagonist, inhibiting stimulated signaling but not basal signaling |
|
| DCC3586 | Ncgc00249987 | Novel allosteric Eya2 phosphatase inhibitor, specifically targeting migration, invadopodia formation, and invasion of lung cancer cells |
|
| DCC3587 | Ncgc00262654 | Novel AMA1-RON2 Inhibitor |
|
| DCC3588 | Ncgc2327 | Novel potent inhibitor of IRAK1/4 and FLT3 |
|
| DCC3589 | Nco-04 | Novel SIRT1 inhibitor, inducing cell death in adult T-cell leukaemia cells |
|
| DCC3590 | Ncrw0005-f05 | Novel GPR139 receptor agonist |
|
| DCC3591 | Ncs-382 | Analogue of γ-hydroxybutyric acid (GHB), acting as a substrate for both the monocarboxylate transporter subtype 1 (MCT1) and subtype 4 (MCT4) |
|
| DCC3592 | Ncs-8591 | Beclin 1 mimetic, selectively binding to Bcl-xL and inducing autophagy, showing potent cytotoxicity in PC-3, PC-3a and DU145 prostate cancer cells |
|
| DCC3593 | Nctu-alan-2026 | Novel blocker of the interaction between FGF1 and FGFRD2 to inhibit cell proliferation, showing potent antiproliferent with less cytotoxicity. |
|
| DCC3594 | ncx-2057 | Novel NO-donor, suppressing inflammatory and nociceptive responses |
|
| DCC3595 | Ncx-6560 | Novel HMG-CoA reductase inhibitor and nitric oxide donor |
|
| DCC3596 | N-cyano-sch-12679 Bromide | Cyanogen Bromide adduct of (R)-SCH-12679, a D1 antagonist |
|
| DCC3597 | Levomepromazine Maleate | Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects |
|
| DCC3598 | Nd1-yl2 | Novel degrader of steroid receptor co-activator 1 (SRC-1) |
|
| DCC3599 | Nd-2110 | Novel potent and highly specific IRAK4 inhibitor |
|
| DCC3600 | Nd-322 Hydrochloride | Selective water-soluble gelatinase inhibitor |
|
| DCC3601 | Nd-364 | Potent and selective inhibitor for gelatinases, matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MPP9) |
|
| DCC3602 | nd7001 | Inhibitor of Phosphodiesterase (PDE)-2 |
|
| DCC3603 | N-demethyldiltiazem | Precursor for radiolabeled diltiazem |
|
| DCC3604 | N-desmethyl Loperamide | Major metabolite of loperamide, also used as the precusor for radiolabelled loperamide |
|
| DCC3605 | Ndi-10 | Novel G4-DNA ligand, promoting transcription in Gram-positive bacteria and repressing transcription in Gram-negatives |
|
| DCC3606 | Ndm-1 Inhibitor-2 | Novel Inhibitor of New Delhi Metallo-β-lactamase-1 (NDM-1) |
|
